Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study
Clinical trial NCT05641831 · RECRUITING
Trial details
- NCT number
- NCT05641831
- Sponsor
- Uma Borate
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-06
- Primary completion
- 2028-12-31
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.